Back to Woodline Partners LP Woodline Partners LP

RCUSRCUS
Showing 8 of 23 quarters

Position history for Woodline Partners LPWoodline Partners LP's holdings in Arcus Biosciences, Inc.

Woodline Partners LP holds 3M shares of RCUS (Arcus Biosciences, Inc.), worth $92.7M as of 2026-Q2. The position was decreased (-20.4% shares). RCUS represents 0.3% of Woodline Partners LP's portfolio.

Current Value

$92.7M

Current Shares

3M

Total Value Change

+$39.5M

Total Shares Change

-470,642

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
3M
-20.4%
$92.7M0.3%$30.83
0
2026-Q1
Increased
3.8M
+0.2%
$81.6M0.3%$22.43
36
2025-Q4
Increased
3.8M
0.0%
$89.8M0.3%$23.23
36
2025-Q3
Decreased
3.8M
-5.8%
$51.3M0.2%$13.32
0
2025-Q2
Decreased
4M
-22.0%
$32.6M0.2%$7.95
0
2025-Q1
Increased
5.1M
+45.5%
$40.2M0.3%$8.17
47
2024-Q4
Increased
3.5M
+1.3%
$52.5M0.4%$14.91
35
2024-Q3
Decreased
3.5M
-18.1%
$53.2M0.4%$15.41
0

Other major holders of RCUS: BlackRock, Inc., BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used